<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d356">
    <sentence id="DDI-DrugBank.d356.s0" text="When amiloride HCl is administered concomitantly with an angiotensin-converting enzyme inhibitor, the risk of hyperkalemia may be increased.">
        <entity id="DDI-DrugBank.d356.s0.e0" charOffset="5-13"
            type="drug" text="amiloride"/>
        <entity id="DDI-DrugBank.d356.s0.e1" charOffset="57-95"
            type="group" text="angiotensin-converting enzyme inhibitor"/>
        <pair id="DDI-DrugBank.d356.s0.p0" e1="DDI-DrugBank.d356.s0.e0"
            e2="DDI-DrugBank.d356.s0.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d356.s1" text="Therefore, if concomitant use of these agents is indicated because of demonstrated hypokalemia, they should be used with caution and with frequent monitoring of serum potassium."/>
    <sentence id="DDI-DrugBank.d356.s2" text="Lithium generally should not be given with diuretics because they reduce its renal clearance and add a high risk of lithium toxicity.">
        <entity id="DDI-DrugBank.d356.s2.e0" charOffset="0-6"
            type="drug" text="Lithium"/>
        <entity id="DDI-DrugBank.d356.s2.e1" charOffset="43-51"
            type="group" text="diuretics"/>
        <pair id="DDI-DrugBank.d356.s2.p0" e1="DDI-DrugBank.d356.s2.e0"
            e2="DDI-DrugBank.d356.s2.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d356.s3" text="Read circulars for lithium preparations before use of such concomitant therapy.">
        <entity id="DDI-DrugBank.d356.s3.e0" charOffset="19-25"
            type="drug" text="lithium"/>
    </sentence>
    <sentence id="DDI-DrugBank.d356.s4" text="In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics.">
        <entity id="DDI-DrugBank.d356.s4.e0" charOffset="42-78"
            type="group" text="non-steroidal anti-inflammatory agent"/>
        <entity id="DDI-DrugBank.d356.s4.e1"
            charOffset="150-153;187-195" type="group" text="loop diuretics"/>
        <entity id="DDI-DrugBank.d356.s4.e2"
            charOffset="156-172;187-195" type="group" text="potassium-sparing diuretics"/>
        <entity id="DDI-DrugBank.d356.s4.e3" charOffset="178-195"
            type="group" text="thiazide diuretics"/>
        <pair id="DDI-DrugBank.d356.s4.p0" e1="DDI-DrugBank.d356.s4.e0"
            e2="DDI-DrugBank.d356.s4.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d356.s4.p1" e1="DDI-DrugBank.d356.s4.e0"
            e2="DDI-DrugBank.d356.s4.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d356.s4.p2" e1="DDI-DrugBank.d356.s4.e0"
            e2="DDI-DrugBank.d356.s4.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d356.s4.p3" e1="DDI-DrugBank.d356.s4.e1"
            e2="DDI-DrugBank.d356.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d356.s4.p4" e1="DDI-DrugBank.d356.s4.e1"
            e2="DDI-DrugBank.d356.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d356.s4.p5" e1="DDI-DrugBank.d356.s4.e2"
            e2="DDI-DrugBank.d356.s4.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d356.s5" text="Therefore, when MIDAMOR and non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.">
        <entity id="DDI-DrugBank.d356.s5.e0" charOffset="16-22"
            type="brand" text="MIDAMOR"/>
        <entity id="DDI-DrugBank.d356.s5.e1" charOffset="28-65"
            type="group" text="non-steroidal anti-inflammatory agents"/>
        <entity id="DDI-DrugBank.d356.s5.e2" charOffset="172-179"
            type="group" text="diuretic"/>
        <pair id="DDI-DrugBank.d356.s5.p0" e1="DDI-DrugBank.d356.s5.e0"
            e2="DDI-DrugBank.d356.s5.e1" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d356.s5.p1" e1="DDI-DrugBank.d356.s5.e0"
            e2="DDI-DrugBank.d356.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d356.s5.p2" e1="DDI-DrugBank.d356.s5.e1"
            e2="DDI-DrugBank.d356.s5.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d356.s6" text="Since indomethacin and potassium-sparing diuretics, including MIDAMOR, may each be associated with increased serum potassium levels, the potential effects on potassium kinetics and renal function should be considered when these agents are administered concurrently.">
        <entity id="DDI-DrugBank.d356.s6.e0" charOffset="6-17"
            type="drug" text="indomethacin"/>
        <entity id="DDI-DrugBank.d356.s6.e1" charOffset="23-49"
            type="group" text="potassium-sparing diuretics"/>
        <entity id="DDI-DrugBank.d356.s6.e2" charOffset="62-68"
            type="brand" text="MIDAMOR"/>
        <pair id="DDI-DrugBank.d356.s6.p0" e1="DDI-DrugBank.d356.s6.e0"
            e2="DDI-DrugBank.d356.s6.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d356.s6.p1" e1="DDI-DrugBank.d356.s6.e0"
            e2="DDI-DrugBank.d356.s6.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d356.s6.p2" e1="DDI-DrugBank.d356.s6.e1"
            e2="DDI-DrugBank.d356.s6.e2" ddi="false"/>
    </sentence>
</document>
